Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI)
Status:
Completed
Trial end date:
1999-03-01
Target enrollment:
Participant gender:
Summary
Didanosine is an effective anti-HIV drug, but it can cause stomach upset. This study tests a
new form of didanosine, ddI EC, a coated pill that passes through the stomach more easily and
hopefully will prevent stomach upset. The purpose of this study is to compare the
effectiveness of ddI EC versus the standard form of ddI. Both forms of ddI will be given with
stavudine (d4T) plus nelfinavir (NLF).